首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Dissecting the role of diazepam-sensitive ??-aminobutyric acid type A receptors in defensive behavioral reactivity to mild threat
【24h】

Dissecting the role of diazepam-sensitive ??-aminobutyric acid type A receptors in defensive behavioral reactivity to mild threat

机译:解剖Diazepam敏感的作用 - 氨基丁酸型受体在防御性行为反应性中对温和威胁的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Moderate reductions in synaptic ??-aminobutyric acidA receptors (GABAARs) have been associated with an enhanced defensive behavioral reactivity to mild threat, sensitive to diazepam. We here tested whether a deficit in ??2 subunit-containing GABAergic synapses is sufficient to cause this anxiety-related phenotype and to prevent its attenuation by the benzodiazepine. Wild type (??2 +/+), heterozygous (??2 +/-) and homozygous (??2 -/-) knock-out littermates were tested in the free-choice exploratory (FCE) and the light/dark choice (LDC) paradigms. ??2 -/- mice, double mutant ??1H101R??2 -/- and ??3H126R??2 -/- mice, which combine a lack of ??2-GABA ARs with point-mutated diazepam-insensitive either ??1H101R or ??3H126R-GABAARs, and double point-mutated ??1H101R?? 2H101R and ??1H101R??3H126R mice were used to uncover the GABA AR subtype(s) mediating the drug effects. Data show that in the FCE, ??2 -/- mice exhibited more retractions (i.e. risk assessment) and longer latencies to first occurrence into the novel compartment and less transitions and time spent inside it in comparison to ??2 +/- and ??2 +/+ mice. In the LDC, ??2 -/- mice visited and spent less time in the lit box and stayed longer in the tunnel than the other two groups. Minor differences were found between ??2 +/- and ??2 +/+ mice in the two paradigms. Diazepam (1.5 mg/kg per os) normalized retractions and latencies in the FCE in ??2 -/- and ??3H126R??2 -/- mice, but not in ??1H101R??2 -/- mice. The same drug treatment failed to attenuate behavioral aversion in both paradigms in all mutants with impaired ??2-GABAAR function. These results reveal ??2-containing GABAARs as key molecular determinants in the regulation of anxiety-related responses elicited by exposure to relative novelty and mild threat. In the absence of these receptors, diazepam through activation of ??1-GABAARs remains effective in reducing risk assessment, but not behavioral aversion. ? 2012 Elsevier Inc. All rights reserved.
机译:突触中适度减少 - 氨基丁酸受体(GABAARs)与增强的防御性行为反应性与温和的威胁有关,对DiazezaM敏感。我们在这里测试了含有缺陷的含亚亚单位的胃肠杆菌突触是否足以使这种焦虑相关的表型并防止苯并二氮杂卓的衰减。在自由选择探索(FCE)和光/黑暗中,在自由选择(FCE)和光/黑暗中测试野生型(β2+ / +)和纯合(?? 2 - / - )敲除凋落物选择(LDC)范式。 ?? 2 - / - 小鼠,双突变体?? 1H101R ?? 2 - / - 和?? 3H126R ?? 2 - / - 小鼠,其与点突变的二氮己蛋白质子不敏感相结合?? 1H101R或?? 3H126R-GABAAR,双点突变?1小时静音?? 2H101R和?? 1H101R ?? 3H126R小鼠揭示介导药物效应的GABA Ar亚型。数据显示,在FCE中,2 - / - 小鼠展示了更多的仲裁(即风险评估)和更长的延迟,以便首先发生进入新颖的隔间,并且与其中,与其中的较少过渡和时间相比?? 2 + / +小鼠。在LDC中,2 - / - 小鼠访问并在LIT盒中花费的时间更少,并且比其他两组在隧道中保持更长。在两个范式中,在2 +/-和?? 2 + / +小鼠之间发现了微细差异。 diazepam(每对1.5 mg / kg)标准化撤回和fce中的延迟在fce中2 - / - 和?? 3h126r ?? 2 - / - 小鼠,但不在?? 1h101r ?? 2 - / - 小鼠。相同的药物治疗未能在所有突变体中衰减两种突变体的行为厌恶?? 2-GABAAR功能。这些结果显示出含有的含有GABAARS作为关键分子决定因素,在通过接触相对新颖性和轻度威胁引起的焦虑相关反应。在没有这些受体的情况下,通过激活的二氮酸泮1-GabaARs在降低风险评估方面仍然有效,但不能行为厌恶。还2012年elsevier Inc.保留所有权利。

著录项

  • 来源
  • 作者单位

    Institute of Pharmacology and Toxicology University of Zurich Winterthurerstrasse 190 8057;

    Laboratory of Genetic Neuropharmacology McLean Hospital and Department of Psychiatry Harvard;

    Institute of Pharmacology and Toxicology University of Zurich Winterthurerstrasse 190 8057;

    Institute of Pharmacology and Toxicology University of Zurich Winterthurerstrasse 190 8057;

    Institute of Pharmacology and Toxicology University of Zurich Winterthurerstrasse 190 8057;

    Institute of Pharmacology and Toxicology University of Zurich Winterthurerstrasse 190 8057;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    ??-Aminobutyric acid type A receptor; Anxiety; Diazepam; Gabra2; Mutant mice;

    机译:?? - 氨基丁酸型受体;焦虑;Diazepam;Gabra2;突变小鼠;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号